Biophan teams up with NASA on nanotechnology:
This article was originally published in Clinica
Biophan Technologies' TE-Bio subsidiary has entered an agreement with NASA, the US aeronautics and space administration, to jointly develop high-density, nanoengineered thermoelectric materials for powering implantable medical devices such as pacemakers. It is also hoped that the technology can be used to develop on-board power for astronaut health monitors. Rochester, New York-based Biophan has a technology portfolio consisting of 80 different patents and pending patent applications either owned by the company or its licensors. Around 30% of these patents and licences were acquired in the last quarter alone, says the firm.
You may also be interested in...
A combined final opinion on the European Chemicals Agency’s proposed microplastic restriction is expected from ECHA committees by year-end, at which point the European Commission will consider whether and when microplastic must be removed from all leave-on cosmetic products marketed in the EU.
Butterfly Network’s CEO Laurent Faracci outlines the company’s growth strategy and plans for their “ultrasound-on-a-chip” technology after its merger with blank check company Longview Acquisition Corp. See what the company’s CEO said about it here.
CDC’s Advisory Committee on Immunization Practices votes 13-1 that these two groups be first in line for vaccination once FDA authorizes a vaccine and ACIP recommends it. Goal of vote is to guide health departments in placing vaccine orders.